Jie Lei

机构：Jiangnan University, Nanjing Agricultural University, Air Force Medical University · ORCID：0000-0002-9971-004X

发表论文 91 篇 · 总被引 1618 次 · h-index 22

代表论文

• LTBR acts as a novel immune checkpoint of tumor‐associated macrophages for cancer immunotherapy (2024 · iMeta · 被引 23)
• Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial) (2024 · Signal Transduction and Targeted Therapy · 被引 19)
• Artificial Friedel–Crafts Alkylase Design With Genetic Incorporated Unnatural S‐(3‐aminophenyl)‐Cysteine (2026 · ChemCatChem · 被引 4)
• Expert Consensus on Subxiphoid and Subcostal Arch Thoracoscopic Resection for the Treatment of Thymoma (2025 · Thoracic Cancer · 被引 4)
• Highly proliferating cancer cells function as novel prognostic biomarkers for lung adenocarcinoma with particular usefulness for stage IA risk stratification (2025 · BMC Cancer · 被引 4)
• Clinical outcomes and short-term survival of neoadjuvant immunochemotherapy for resectable esophageal cancer: a multicenter retrospective cohort study (2024 · International Journal of Surgery · 被引 4)